EcoR1 Capital β Full Portfolio
71 tracked investments Β· listed companies and verified rows first
Aktis Oncology discovers and develops targeted radiopharmaceuticals for treating solid tumors.
BiotechHealthtechMedical DevicesBoston, US
Todd Foley(Co-founder and Chairman)Patrick Baeuerle(Co-founder & Advisor)Shulamit Ron-Bigger(Executive Officer)
BoardHelen S. Kim(Director)Andrew Levin(Director)
Board seatOleg NodelmanΒ· per SEC Form D
Atara Biotherapeutics develops allogeneic T-cell immunotherapies using its proprietary EBV T-cell platform to harness the immune system for treating disease.
BiotechHealthtechMedical DevicesThousand Oaks, US
aTyr is a clinical-stage biotechnology company developing therapies derived from tRNA synthetase biology to treat fibrosis and inflammation, with its lead candidate efzofitimod in clinical trials for interstitial lung disease.
BiotechHealthtechMedical DevicesSan Diego, US
Amir Nashat(Non-Management Director)Paul Schimmel(Non-Management Director)Akkaraju Srinivas(Non-Management Director)John D. Mendlein(Executive Officer, Director)David Weiner(Executive Officer)Ed Penhoet(Non-Management Director)
BiotechCanton, US
Gino Santini(Director)Eran Nadav(Director)John Freund(Director)Garen Bohlin(Director)David Hirsch(Director)Michael Heffernan(Executive Officer, Director)
Denali Therapeutics develops therapeutics for neurodegenerative diseases.
BiotechHealthtechMedical DevicesSan Francisco, US
Carole Ho(Executive Officer)Vicki L. Sato(Director)Nancy A. Thornberry(Director)Peter S. Klein(Director)Marc Tessier-Lavigne(Director)Jay T. Flatley(Director)
Editas Medicine develops gene-editing medicines using CRISPR technology to treat serious genetic diseases.
BiotechMedical Devices
Freenome develops early-stage cancer detection technology using blood tests to identify cancer in its earliest, most treatable phases.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesLondon
Riley Ennis(Co-Founder and Chief Product Officer)Stuart Lawson(Director)Charles Roberts(Director)Gabriel Otte(Director)
Gossamer Bio is a clinical-stage biopharmaceutical company developing seralutinib, an investigational drug candidate for treating pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.
BiotechDigital HealthMedical DevicesSan Diego, US
Bryan Giraudo(Executive Officer)Faheem Hasnain(Executive Officer, Director)Russell Cox(Director)Renee Gala(Director)Laura Carter, Ph.D.(Executive Officer)Christian Waage(Executive Officer)
BiotechCambridge, US
Nessan Bermingham(Executive Officer, Director)Jose Rivera(Executive Officer)Carl Gordon(Director)Jean-Francois Formela(Director)John Leonard(Executive Officer, Director)Rachel Haurwitz(Director)
Kura Oncology is a company in the oncology/medtech sector that provides grant support for independent medical education programs designed to enhance healthcare professionals' ability to diagnose and treat patients in Kura Oncology's therapeutic areas of interest.
BiotechDigital HealthMedical DevicesLa Jolla, US
HEIDI HENSON(Executive Officer)TROY WILSON(Executive Officer, Director)ANNETTE NORTH(Executive Officer)PINGDA REN(Executive Officer)YI LIU(Executive Officer)ANTONIO GUALBERTO(Executive Officer)
ORIC Pharmaceuticals is a clinical-stage oncology company founded in 2014 to develop cancer therapies that address treatment resistance, with the aim of extending the effectiveness of existing therapies.
BiotechHealthtechSouth San Francisco, US
Richard Heyman(Chairman, Founder, Scientific Advisory Board)Jacob M. Chacko(Executive Officer, Director)Dominic Piscitelli(Chief Financial Officer)Pratik Multani(Chief Medical Officer)Mardi Dier(Director)Charles Sawyers(Founder, Scientific Advisory Board)
Scholar Rock is a biopharmaceutical company that develops therapies targeting growth factor proteins to treat serious diseases.
BiotechCambridge, US
Katrine Bosley(Director)Michael Gilman(Director)Nagesh Mahanthappa(Executive Officer, Director)Timothy Springer(Director)
BoardKristina Burow(Director)Amir Nashat(Director)
BiotechAustin, US
Walter Loewenbaum(Director)Josiah Hornblower(President/CEO)
Dewpoint Therapeutics develops condensate-modulating drugs by using an integrated platform that maps, measures, and modulates biomolecular condensates to identify druggable targets and disease mechanisms.
AI & Machine LearningBiotechDeep TechBoston, US
Mark Murcko, Ph.D.(Director)Richard Young, Ph.D.(Director)Elisabeth Leiderman(Executive Officer)Ameet Nathwani, M.D.(Executive Officer, Director)Isaac Klein, M.D., Ph.D.(Executive Officer)Lori Escobedo(Executive Officer)
Epikast provides medically trained talent and AI-driven engagement tools to biopharma and healthcare organizations for communicating with healthcare professionals and patients across the US and Europe.
AI & Machine LearningHealthtechBrooklyn, US
Evangelos Vergetis(Executive Officer, Director)
BoardBrad Prosek(Director)Stelios Papadopoulos(Director)Daphne Karydas(Director)Alexandros Tzoukas(Director)
Board seatOleg NodelmanΒ· per SEC Form D
Menlo Park, US
Board seatOleg NodelmanΒ· per SEC Form D Β· $290M raise Β· filed Sep 2023
BiotechBoston, US
Adam Friedman(Executive Officer, Director)Andrew Fedder(Executive Officer)Darrin Stuart(Executive Officer)Erica Jackson(Executive Officer)Amanda Valentino(Executive Officer)Gary Glick(Executive Officer, Director)
Board seatOleg NodelmanΒ· per SEC Form D
Affinia Therapeutics develops genetically engineered adeno-associated virus (AAV) therapies for treating genetic diseases, focusing initially on cardiovascular and central nervous system conditions.
AI & Machine LearningBiotechDeep TechWaltham, US
Luc Vandenberghe(Director)Rami Daoud(Executive Officer)Rick Modi(Executive Officer, Director)Laura Richman(Executive Officer)Petra Kaufmann(Executive Officer)Robert Aboud(Executive Officer)
Affinivax was a clinical-stage biopharmaceutical company that developed next-generation pneumococcal vaccines using its proprietary Multiple Antigen Presenting System (MAPS) platform technology.
BiotechMedical DevicesCambridge, US
Richard Malley(Director)Robert More(Director)Frances Heller(Director)Kamran Tavangar(Executive Officer)George Siber(Director)Steven Brugger(Executive Officer, Director)
BiotechNew York, US
Martin Vogelbaum(Executive Officer, Director)Ross Levine(Director)Ramy Farid(Director)
BoardScott Platshon(Director)
Akouos is a precision genetic medicine company developing therapies for the inner ear to restore, improve, and preserve hearing.
BiotechHealthtechBrookline, US
Emmanuel Simons(Executive Officer, Director)Kush Parmar(Director)
BoardEd Mathers(Director)
Kalaris Therapeutics is a clinical-stage biopharmaceutical company developing retinal disease treatments, specifically engineered biologics for wet AMD, diabetic eye disease, and retinal vein occlusion.
BiotechDigital HealthMedical DevicesBerkeley Heights, US
Napoleone Ferrara(Director & Co-Founder)Srinivas Akkaraju(Director & Co-founder)Mike Dybbs(Director & Co-founder)
Anagin develops targeted therapies for neurological and psychiatric diseases caused by disrupted synaptic plasticity, including PTSD, traumatic brain injury, depression, neuropathic pain, Alzheimer's, and Parkinson's disease.
BiotechDigital HealthMedical DevicesIndianapolis, US
Nora Doherty(Director)Derek Small(Director)Yvonne Lai(Executive Officer)Anantha Shekhar(Director)Jaswant Gidda(Executive Officer, Director)James Schulz(Executive Officer)
BiotechRedwood City, US
William Robinson(Director)Lawrence Steinman(Director)Tito Serafini(Executive Officer, Director)Franklin Berger(Director)Brian Atwood(Director)
Attovia develops precision biologics using its ATTOBODY platform for patients with immune-mediated diseases.
BiotechDigital Health
AVTTX is a clinical-stage company developing gene therapy treatments for retinal and ophthalmologic diseases.
BiotechDigital HealthHealthtechMedical Devices
George Montgomery(Executive Chairman)
Cellares develops automated manufacturing systems and technology platforms to accelerate the production and commercialization of cell therapies.
Advanced ManufacturingBiotechMedical DevicesSouth San Francisco, US
Fabian Gerlinghaus(Co-Founder and Chief Executive Officer)inOmar Kurdi(Co-Founder and President)inVictor Tong(Director)in
BoardJustin Butler(Director)
Centessa Pharmaceuticals is developing an Orexin Receptor 2 Agonist program to treat sleep-wake, neurological, neurodegenerative, and neuropsychiatric disorders.
BiotechHealthtech
ElevateBio is a contract development and manufacturing organization (CDMO) that provides end-to-end services for cell and gene therapies, from discovery and process development through clinical and commercial-scale manufacturing.
BiotechDeep TechMedical Devices
Mike Paglia(Chief Technology Officer)
Flex Pharma provides accessible generic vasodilator medications, including PDE5 inhibitors, to U.S. patients at lower costs than brand-name alternatives.
BiotechDigital HealthHealthtechMedical Devices
Dr. Rod MacKinnon(Founder)
BiotechNew York, US
Rebecka Belldegrun, M.D.(Director)Otello Stampacchia, Ph.D.(Director)David M. Tanen(Executive Officer, Director, Promoter)John C. Martin, Ph.D.(Director)Norbert Bischofberger, Ph.D.(Executive Officer, Director)Arie S. Belldegrun, M.D.(Director)
BiotechSan Diego, US
Yi Liu(Executive Officer, Director)Lynn Yang(Director)
BoardCarl Gordon(Director)
BiotechSan Diego, US
Trisha Millican(Executive Officer)Ken Song(Executive Officer, Director)Ronald Evans(Director)
BoardKristina Burow(Director)Richard Heyman(Director)Amir Nashat(Director)
HealthtechWest Lafayette, US
Sunil Singhal, M.D.(Director)Philip Low, Ph.D.(Director)Isaac Barchas(Director)Clay B. Siegall, Ph.D.(Executive Officer, Director)Ronald Martell(Director)Franklyn Prendergast, M.D., Ph.D.(Director)
NiKang Therapeutics is a clinical-stage biotech company developing small molecule drugs for cancer treatment, focusing on HIF2Ξ±, CDK2, and KRAS targets using structure-based drug design.
Biotech
BiotechSan Francisco, US
Jonathan Winger(Executive Officer, Director)Stephen Cary(Executive Officer, Director)John Wesley(Director)Ajit Shah(Director)
BoardJeffrey S. Samberg(Director)Laurence Marton(Director)
Paratus Sciences develops first-in-class medicines for cardiometabolic and immune & inflammatory diseases by leveraging evolutionary biology and AI to identify novel drug targets.
AI & Machine LearningBiotechDeep TechUnited States, US
BiotechMenlo Park, US
Ervin Epstein(Executive Officer, Director)Jean Tang(Director)Mark de Souza(Executive Officer)Katrin Andreasson(Director)
ARS Pharma develops needle-free epinephrine therapy, marketing neffy, an FDA-approved epinephrine nasal spray designed to be easy to carry and use.
BiotechDigital HealthMedical DevicesSeattle, US
Peter A. Thompson(Executive Officer, Director)
Tectonic is a clinical-stage biotechnology company developing therapeutic proteins and antibodies that target G-Protein Coupled Receptors (GPCRs) using a proprietary platform called GEODeβ’.
AI & Machine LearningBiotechMedical DevicesWatertown, US
Timothy A. Springer(Co-Founder)Andrew C. Kruse
Brisbane, US
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.